While it’s highly experimental, surprising early research suggests it may reprogram misfiring heart cells to control heartbeats more like younger, healthier cells do.
Michelle Logeot refers to the biggest health scare of her life as 'the event,' the type she does not want other women to experience when doctors misdiagnose them or dismiss symptoms of a potentially deadly heart attack.
Results show no difference in risk of stroke, myocardial infarction or pulmonary embolism with Pfizer monovalent versus Pfizer bivalent COVID-19 boosters.